Abstract
Sarcopenia is having a serious impact on highly aged populations. A Japanese traditional medicinal remedy containing Schisandra fruits and Astragalus roots recently showed effective treatment of sarcopenia and thus needed to be investigated further. This current study selected Schisandra cauliflora fruits for investigation of their chemical constituents and evaluation of their antisarcopenia effects. Dried S cauliflora fruits were ultrasonically extracted with methylene chloride. This extract was purified by a combination of chromatographic techniques. The isolated compounds were characterized by nuclear magnetic resonance spectroscopy, electronic circular dichroism, and high resolution electrospray ionization mass spectrometry methods. Antisarcopenia activities of the isolated compounds were evaluated by their effects on the viability and proliferation of C2C12 skeletal muscle cells. Seven dibenzocyclooctadiene lignans, including 2 that had been previously undescribed, cauliflorins A and B (
Introduction
The elderly populations and age-related diseases have been receiving attention in recent decades.1,2 Sarcopenia, a natural loss in both mass and strength of skeletal muscle, is one of the main challenges of elderly people. It is reported that the loss in mass and strength of skeletal muscle starts after the age of 40 and rapidly accelerates with increasing age. Elderly people over 80 years old lose ∼50% of their muscle mass and strength in the next decade.2,3 Japan is known to have a highly aged population. Prevention and/or treatment of sarcopenia therefore is of much concern to the Japanese Ministry of Health. A Japanese traditional medicinal remedy, called ninjin’yoeito, recently showed positive signs in the treatment of sarcopenia. 4 The study suggested that Schisandra fruits and Astragalus roots are active ingredients of the ninjin’yoeito formula and suggested that further investigations on these herbs were needed for the treatment of sarcopenia. 5 In this report, we describe the discovery of 2 previously undescribed and 5 known dibenzocyclooctadiene lignans from the fruits of Schisandra cauliflora. The isolated compounds were also screened for antisarcopenia activity by evaluation of their effects on the viability and proliferation of C2C12 skeletal muscle cells.
Results and Discussion
The fruits of S cauliflora were finely ground and ultrasonically macerated in methylene chloride (MC). The MC soluble fraction was separated and purified by chromatographic techniques to yield compounds
The molecular formula of

Structure of 7 dibenzocyclooctadien lignans isolated from Schisandra cauliflora fruits.

Important COSY (H─H) and HMBC (H→C) interactions for

Key rotating frame Overhauser effect spectroscopy (ROESY) interactions for
The HR-ESI-MS of
The NMR and ECD spectral data of other compounds, respectively, consisted of known dibenzocycloortadiene lignans, including ananolignan C (
Schisandrins are well-known dibenzocyclooctadiene lignans and are major constituents of Schisandra fruits.
13
They are believed to be responsible for their antisarcopenia activity.
5
Thus, the 7 isolated dibenzocyclooctadiene lignans (
Material and Methods
General
General experimental procedures and bioassay are given in the Supplementary File.
Extraction and Purification
The fruits of S cauliflora were dried overnight and then finely pulverized. Powdered fruits (1.0 kg) were extracted with MC (3 times, each 3 L of MC, 60 min in an ultrasonic bath). The extract solution was filtered through filter paper, and the solvent was evaporated to give the crude extract. This (35 g) was roughly separated by silica gel column chromatography, eluting with increasing quantities of acetone in n-hexane (0%-100% in volume) to give 8 fractions, SFD1-SFD8. Fraction SFD3 (5.2 g) was subjected to reversed phase column chromatography, eluting with methanol in water (75% methanol), to yield 4 fractions, SFD3A-SFD3D. Fraction SFD3B was equally divided into 2 portions, SFD3B1 and SFD3B2. The SFD3B1 portion was injected into a semipreHPLC column, running with CH3CN/H2O (60/40) to give
Cauliflorin A (1 )
Yellow amorphous powder; [α]D29: +27 (c 0.1, MeOH); ECD (MeOH) θ(λ nm): +20.9(212), −18.1(251) mdeg; HR-ESI-MS: m/z 483.1996 [M + Na]+ (Calcd. for [C25H32O8 + Na]+, 483.1989); 1H NMR and 13C NMR data shown in Table 1.
1H and 13C Nuclear Magnetic Resonance (NMR) Data for
125 MHz.
500 MHz.
*Overlapped signals.
ND, not detected due to low intensity.
Cauliflorin B (2 )
Yellow amorphous powder; [α]D29: +51 (c 0.1, MeOH); ECD (MeOH) θ(λ nm): +10.6(216), −7.6(251) mdeg; HR-ESI-MS: m/z 471.1996 [M + Na]+ (calcd. for [C24H32O8 + Na]+, 471.1989); 1H NMR and 13C NMR data shown in Table 1.
Conclusions
Purification of the MC extract of S cauliflora fruits resulted in the isolation of 7 dibenzocyclooctadiene lignans. Two of them (cauliflorins A and B,
Supplemental Material
sj-docx-1-npx-10.1177_1934578X231176406 - Supplemental material for Discovery of 2 New Dibenzocyclooctadiene Lignans Cauliflorins A and B From Schisandra cauliflora
Supplemental material, sj-docx-1-npx-10.1177_1934578X231176406 for Discovery of 2 New Dibenzocyclooctadiene Lignans Cauliflorins A and B From Schisandra cauliflora by Bui Thi Thu Trang, Nguyen Huy Hoang, Pham Hai Yen and Do Thi Trang, Nguyen Thi Cuc, Duong Thi Hai Yen, Jinyoung Kim, Junjung Choi, Seung Hyun Kim, Bui Huu Tai, Nguyen Xuan Nhiem, Phan Van Kiem in Natural Product Communications
Footnotes
Declaration of Conflicting Interests
The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Ethical Approval
Our institution does not require ethical approval for reporting individual cases or case series.
Funding
The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by the Vietnam Academy of Science and Technology (VAST) under grant number QTKR01.01/21-22.
Statement of Human and Animal Rights
This article does not contain any studies with human or animal subjects.
Statement of Informed Consent
There are no human subjects in this article and informed consent is not applicable.
Supplemental Material
Supplemental material for this article is available online.
References
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
